MedPath

The study of investigating the genetic profiles of Exceptional Response in cancer therapies.

Not Applicable
Recruiting
Conditions
Cancer patient who received therapies.
Registration Number
JPRN-UMIN000016643
Lead Sponsor
ational Cancer Center Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Judged ineligible by the clinical investigators

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analysis of somatic gene mutation, gene expression of tumor tissue
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath